View in EDS

SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM).

Saved in:
Bibliographic Details
Title: SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM).
Authors: SAMYSHKIN, Yevgeniy1 (AUTHOR), Purser, Molly2 (AUTHOR), Dlotko, Ewa3 (AUTHOR), Macleod, Paul3 (AUTHOR), Breslin, Katie3 (AUTHOR), Boytsov, Natalie2 (AUTHOR), McNamara, Simon4 (AUTHOR), Sapra, Sandhya2 (AUTHOR), Suvannasankha, Attaya5 (AUTHOR)
Source: Value in Health. 2025 Supplement 1, Vol. 28 Issue 6, pS399-S399. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 186589254
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22SAMYSHKIN%2C+Yevgeniy%22">SAMYSHKIN, Yevgeniy</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Purser%2C+Molly%22">Purser, Molly</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dlotko%2C+Ewa%22">Dlotko, Ewa</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Macleod%2C+Paul%22">Macleod, Paul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Breslin%2C+Katie%22">Breslin, Katie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boytsov%2C+Natalie%22">Boytsov, Natalie</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McNamara%2C+Simon%22">McNamara, Simon</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sapra%2C+Sandhya%22">Sapra, Sandhya</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Suvannasankha%2C+Attaya%22">Suvannasankha, Attaya</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2025 Supplement 1, Vol. 28 Issue 6, pS399-S399. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186589254
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2025.04.1780
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S399
    Titles:
      – TitleFull: SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: SAMYSHKIN, Yevgeniy
      – PersonEntity:
          Name:
            NameFull: Purser, Molly
      – PersonEntity:
          Name:
            NameFull: Dlotko, Ewa
      – PersonEntity:
          Name:
            NameFull: Macleod, Paul
      – PersonEntity:
          Name:
            NameFull: Breslin, Katie
      – PersonEntity:
          Name:
            NameFull: Boytsov, Natalie
      – PersonEntity:
          Name:
            NameFull: McNamara, Simon
      – PersonEntity:
          Name:
            NameFull: Sapra, Sandhya
      – PersonEntity:
          Name:
            NameFull: Suvannasankha, Attaya
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2025 Supplement 1
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 10983015
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Value in Health
              Type: main
ResultId 1